Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples